IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
82 hedge funds and large institutions have $305M invested in IGM Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $402M → $305M (-$97M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
82
Holding in Top 10
–
Calls
$1.07M
Puts
$165K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$1.87M | |
| 3 | +$1.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$973K |
| 5 |
D.E. Shaw & Co
New York
|
+$897K |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$2.18M | |
| 3 | -$885K | |
| 4 |
Goldman Sachs
New York
|
-$856K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$851K |